Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evenity in postmenopausal women with osteoporosis (FRAME)
NCT01575834Phase 3Completed
- Sponsor
- Amgen
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Countries
- 24
01
Overview
A Phase 3 trial of romosozumab in postmenopausal osteoporosis, sponsored by Amgen. Started Mar 2012; status: completed.
02
Drugs
romosozumab
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01575834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575834.